Literature DB >> 28993155

Cardiac autonomic neuropathy may play a role in pathogenesis of atherosclerosis in type 1 diabetes mellitus.

Sarka Mala1, Veronika Potockova2, Lucie Hoskovcova3, Pavlina Pithova3, Marek Brabec4, Jaroslava Kulhankova5, Radan Keil3, Lucie Riedlbauchova6, Jan Broz3.   

Abstract

AIMS: Cardiac autonomic neuropathy (CAN) is a frequent and severe complication of type 1 diabetes mellitus (T1DM). CAN diagnosis is associated with increased cardiovascular morbidity and mortality, often due to progressive atherosclerosis. Carotid intima media thickness (CIMT) is a surrogate marker of the atherosclerosis. The aim of our study was to evaluate the relationship between CIMT and CAN in T1DM patients.
METHODS: Total of 49 T1DM patients and 45 healthy controls were examined for CAN presence and CIMT. CAN was diagnosed based on the results of Ewing test battery and spectral analysis of heart rate variability. CIMT was measured by two-dimensional ultrasound. Biochemical, anthropometric and anamnestic risk markers of atherosclerosis were evaluated. We used logistic types of generalized additive models (GAM) for statistical analysis.
RESULTS: CAN was detected in 22 out of 49 T1DM patients (45%). All 45 healthy controls had normal cardiovascular autonomic tests results. CIMT was significantly positively associated with T1DM diagnosis (p=0.0251), CAN diagnosis (p=0.007), age (p<0.0001), BMI (p=0.0435) and systolic blood pressure (p=0.0098). CAN effect on CIMT interacted with the effect of T1DM. The combination of both factors significantly increased CIMT more than the sum of the individual T1DM and CAN status.
CONCLUSIONS: CAN is significantly associated with higher CIMT in T1DM patients. CAN may play a role in pathogenesis of atherosclerosis in type 1 diabetes mellitus.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Autonomic neuropathy; Diabetes mellitus; Heart rate variability; Intima media thickness

Mesh:

Year:  2017        PMID: 28993155     DOI: 10.1016/j.diabres.2017.10.002

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

Review 1.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

Review 2.  The Potential of Current Noninvasive Wearable Technology for the Monitoring of Physiological Signals in the Management of Type 1 Diabetes: Literature Survey.

Authors:  Elena Daskalaki; Anne Parkinson; Nicola Brew-Sam; Md Zakir Hossain; David O'Neal; Christopher J Nolan; Hanna Suominen
Journal:  J Med Internet Res       Date:  2022-04-08       Impact factor: 7.076

3.  Letter: Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea (Diabetes Metab J 2017;41:275-83).

Authors:  Jeongmin Lee; Jae Hyoung Cho
Journal:  Diabetes Metab J       Date:  2017-10       Impact factor: 5.376

4.  Leukotriene Pathway Activation Associates with Poor Glycemic Control and with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes.

Authors:  Daniele P Santos-Bezerra; Luciano R Filgueiras; Maria Beatriz Monteiro; Sharon N Admoni; Ricardo V Perez; Ana M Cavaleiro; Cleide G Machado; Ubiratan F Machado; Marisa Passarelli; Sonia Jancar; Maria Lucia Correa-Giannella
Journal:  Mediators Inflamm       Date:  2020-03-23       Impact factor: 4.711

5.  Association between Cardiac Autonomic Neuropathy and Coronary Artery Lesions in Patients with Type 2 Diabetes.

Authors:  Lei Liu; Qiansheng Wu; Hong Yan; Baoxian Chen; Xilong Zheng; Qiang Zhou
Journal:  Dis Markers       Date:  2020-12-30       Impact factor: 3.434

6.  Peripheral Nerve Conduction And Sympathetic Skin Response Are Reliable Methods to Detect Diabetic Cardiac Autonomic Neuropathy.

Authors:  Xiaopu Lin; Chuna Chen; Yingshan Liu; Yu Peng; Zhenguo Chen; Haishan Huang; Lingling Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-21       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.